retatrutide 2 months VisualAbstract: reduces body weight by 17.5% in patients with obesity Phase 2 trial results demonstrate

GLP-1 receptor agonists have been shown to reduce systemic inflammation, improve insulin sensitivity, and influence metabolic pathways that may contribute to tumor initiation and growth

Phytochemistry 156:124134

Interestingly, new research published in the journal Nature Medicine evaluated the health outcomes of more than 2 million veterans with diabetes taking a GLP-1 and found that while the medications had positive effects on several health conditions, like heart disease and substance use disorders, they were negatively associated with some, including arthritis

Enriched with Saffron: Helps improve natural brightness and gives the skin a healthy, refreshed glow

Are the days getting shorter